Flagship Biosciences and Leap Therapeutics announce partnership and approach using RNAscope and Image Analysis for patient enrollment

Flagship Biosciences and Leap Therapeutics announce partnership and approach using RNAscope and Image Analysis for patient enrollment

WESTMINSTER and CAMBRIDGE, Mass. -- Flagship Biosciences , a leader in data-centric pathology and tissue analysis, and Massachusetts-based Leap Therapeutics (Nasdaq: LPTX), a biotechnology... Read More

Wednesday April 14, 2021 0 comments Tags: Westminster, Flagship Biosciences, Leap Therapeutics, Trevor Johnson

Maxar delivers spacecraft bus for NASA’s Psyche Mission to explore asteroid

Maxar delivers spacecraft bus for NASA’s Psyche Mission to explore asteroid

WESTMINSTER -- Maxar Technologies (NYSE:MAXR) (TSX:MAXR) announced the delivery of the Solar Electric Propulsion (SEP) Chassis to NASA’s Jet Propulsion Laboratory (JPL) for the NASA Discovery... Read More

Tuesday March 30, 2021 0 comments Tags: Westminster, Maxar Technologies, Psyche, NASA, Robert Curbeam

Maxar awarded contract to support GEOINT exploitation for U.S. Army and combatant commands

Maxar awarded contract to support GEOINT exploitation for U.S. Army and combatant commands

WESTMINSTER -- Maxar Technologies (NYSE:MAXR) (TSX:MAXR) today announced it was awarded a U.S. Army contract worth as much as $48.3 million for support services in geospatial intelligence (GEOINT).... Read More

Monday March 29, 2021 0 comments Tags: Westminster, Maxar Technologies, Tony Frazier

Flagship Biosciences announces new patent

Flagship Biosciences announces new patent

WESTMINSTER -- Flagship Biosciences announced the United States Patent and Trademark Office has issued the company a new patent, No. 10,839,512, entitled “ Method of dot detection within images... Read More

Thursday February 18, 2021 0 comments Tags: Westminster, Flagship Biosciences, Trevor Johnson

Maxar Technologies appoints Heather Wilson to board of directors

Maxar Technologies appoints Heather Wilson to board of directors

WESTMINSTER -- Maxar Technologies (NYSE:MAXR) (TSX:MAXR) today announced the appointment of Dr. Heather Wilson to serve on the company’s board of directors. Wilson will serve as a director... Read More

Tuesday January 19, 2021 0 comments Tags: Westminster, Maxar Technologies, Heather Wilson, Dan Jablonsky

Cerapedics announces commercial launch of i-FACTOR®+ Matrix in Canada for surgeries

Cerapedics announces commercial launch of i-FACTOR®+ Matrix in Canada for surgeries

WESTMINSTER -- Cerapedics announced the full commercial availability of i-FACTOR+ MATRIX for surgical implantation in Canada. "We are excited to announce that i-FACTOR+ Matrix is now fully... Read More

Friday November 6, 2020 0 comments Tags: Westminster, Cerapedics, i-FACTOR+Matrix, Glen Kashuba, Jeffrey Marx

TriSalus Life Sciences lays out therapeutic strategy upon acquisition of first therapeutic candidate

TriSalus Life Sciences lays out therapeutic strategy upon acquisition of first therapeutic candidate

DENVER and CHICAGO -- TriSalus Life Sciences (TriSalus), an emerging immune-oncology company committed to transforming outcomes for patients with solid tumors, announced its therapeutic clinical... Read More

Monday September 28, 2020 0 comments Tags: Westminster, TriSalus Life Sciences, SD-101, Mats Wahlstrom, Mary Szela, Steven Katz

Maxar awarded contract to build sixth geostationary communications satellite for Intelsat in 2020

Maxar awarded contract to build sixth geostationary communications satellite for Intelsat in 2020

WESTMINSTER -- Maxar Technologies (NYSE:MAXR) (TSX:MAXR) today announced it will build the Galaxy 37 geostationary communications satellite for Intelsat , operator of the world’s largest... Read More

Thursday September 17, 2020 0 comments Tags: Westminster, Maxar Technologies, Intelsat, Megan Fitzgerald